Feasibility of ceramic-polymer composite cryogels as scaffolds for bone tissue engineering

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 6, 2012, Pages 421-433

  Rodriguez Lorenzo, Luis M ^a,b   Saldaña, Laura ^b,c   Benito Garzón, Lorena ^a,b   García Carrodeguas, Raul ^d   de Aza, Salvador ^d   Vilaboa, Nuria ^b,c   Román, Julio San ^a,b  

^a INSTITUTO DE CIENCIA Y TECNOLOGÍA DE POLÍMEROS   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^d INSTITUTO DE CERÁMICA Y VIDRIO   (Spain)

Author keywords

Bone tissue engineering; Composites; Cryogels; Interactions; Mesenchymal stem cells; Scaffold

Indexed keywords

BIOCOMPATIBILITY; BONE; CELL ENGINEERING; PORE SIZE; SCAFFOLDS (BIOLOGY); SILICATE MINERALS; STEM CELLS;

'CURRENT; 2-HYDROXYETHYL METHACRYLATE; BONE TISSUE ENGINEERING; CERAMIC-POLYMER COMPOSITES; COMPOSITE CRYOGELS; CRYOGELS; CRYOPOLYMERIZATION; INTERACTION; INTERCONNECTION SIZE; MESENCHYMAL STEM CELL;

CELL CULTURE;

2 HYDROXYETHYL METHACRYLATE; ACRYLIC ACID; CALCIUM SILICATE; FIBRONECTIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; OSTEOPROTEGERIN; TISSUE SCAFFOLD;

ADIPOSE TISSUE STEM CELL; ARTICLE; BIOCOMPATIBILITY; BONE REMODELING; BONE TISSUE; CELL ADHESION; CELL CULTURE; CELL GROWTH; CELL ISOLATION; CELL STRUCTURE; CELL VIABILITY; CERAMICS; COMPOSITE MATERIAL; CONTROLLED STUDY; CRYOGEL; CULTURE MEDIUM; EXTRACELLULAR MATRIX; HEMATOPOIETIC STEM CELL; MESENCHYMAL STEM CELL; OSSIFICATION; POLYMERIZATION; POROSITY; PRIORITY JOURNAL; PROTEIN SECRETION; TISSUE ENGINEERING; YOUNG MODULUS;

EID: 84860685863     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.443     Document Type: Article

References (56)

1. Aguilar MR, Gallardo A, Lechuga LM, et al. 2004; Modulation of proteins adsorption onto the surface of chitosan complexed with anionic copolymers. real time analysis by surface plasmon resonance. Macromol Biosci 4: 631-38.
2. Alford AI, Hankenson KD. 2006; Matricellular proteins: Extracellular modulators of bone development, remodeling, and regeneration. Bone 38: 749-57.
3. Baneyx G, Baugh L, Vogel V. 2001; Coexisting conformations of fibronectin in cell culture imaged using fluorescence resonance energy transfer. Proc Natl Acad Sci U S A 98: 14464-68.
4. Bolgen N, Yang Y, Korkusuz P, et al. 2008; Three-dimensional ingrowth of bone cells within biodegradable cryogel scaffolds in bioreactors at different regimes. Tissue Eng Part A 14: 1743-50.
5. Bosetti M, Boccafoschi F, Calarco A, et al. 2008; Behaviour of human mesenchymal stem cells on a polyelectrolyte-modified HEMA hydrogel for silk-based ligament tissue engineering. J Biomater Sci Polym Ed 19: 1111-23.
6. Chastain SR, Kundu AK, Dhar S, et al. 2006; Adhesion of mesenchymal stem cells to polymer scaffolds occurs via distinct ECM ligands and controls their osteogenic differentiation. J Biomed Mater Res A. 78: 73-85.
7. Christenson EM, Anseth KS, van den Beucken L, et al. 2007; Nanobiomaterial applications in orthopedics. J Orthop Res 25: 11-22.
8. Collins AM, Skaer NJV, Cheysens T, et al. 2009; Bone-like resorbable silk-based scaffolds for load-bearing osteoregenerative spplications. Adv Mater 21: 75-78.
9. Cristino S, Grassi F, Toneguzzi S, et al. 2005; Analysis of mesenchymal stem cells grown on a three-dimensional HYAFF 11-based prototype ligament scaffold. J Biomed Mater Res A 73: 275-283.
10. Dadsetan M, Hefferan TE, Szatkowski JP, et al. 2008; Effect of hydrogel porosity on marrow stromal cell phenotypic expression. Biomaterials 29: 2193-2202.
11. De Aza PN, Guitian F, Merlos A, et al. 1996; Bioceramics-simulated body fluid interfaces: pH and its influence on hydroxyapatite formation. J Mater Sci Mater Med 7: 399-402.
12. Dubruel P, Unger R, Van Vlierberghe S, et al. 2007; Porous gelatin hydrogels: 2. In vitro cell interaction study. Biomacromolecules 8: 338-344.
13. Dufrane D, Delloye C, Mckay IJ, et al. 2003; Indirect cytotoxicity evaluation of pseudowollastonite. J Mater Sci Mater Med 14: 33-38.
14. Dyson JA, Genever PG, Dalgarno KW, et al. 2007; Development of custom-built bone scaffolds using mesenchymal stem cells and apatite-wollastonite glass-ceramics. Tissue Eng 13: 2891-2901.
15. El-Amin SF, Attawia M, Lu HH, et al. 2002; Integrin expression by human osteoblasts cultured on degradable polymeric materials applicable for tissue engineered bone. J Orthop Res 20: 20-28.
16. Fernandez E, Lopez D, Lopez-Cabarcos E, et al. 2005; Viscoelastic and swelling properties of glucose oxidase loaded polyacrylamide hydrogels and the evaluation of their properties as glucose sensors. Polymer 46: 2211-2217.
17. García Carrodeguas R, De Aza A, De Aza PN, et al. 2007; Assessment of natural and synthetic wollastonite as source for bioceramics preparation. J Biomed Mater Res A 83: 484-495.
18. Garrido L. 1999; Non-destructive evaluation of biodegradable porous matrices for tissue engineering. In Methods in Molecular Medicine, Morgan JR, Yarmush ML (eds). Humana: Totowa, NJ; 35-45.
19. Graziano A, d'Aquino R, Cusella-De Angelis MG, et al. 2008; Scaffold's surface geometry significantly affects human stem cell bone tissue engineering. J Cell Physiol 214: 166-172.
20. Gross KA, Rodríguez-Lorenzo LM. 2004; Biodegradable composite scaffolds with an interconnected spherical pore network for bone tissue engineering. Biomaterials 25: 4955-4962.
21. Hidalgo-Bastida LA, Cartmell SH. 2010; Mesenchymal stem cells, osteoblasts and extracellular matrix proteins: enhancing cell adhesion and differentiation for bone tissue engineering. Tissue Eng B Rev 16: 405-412.
22. Izadpanah R, Trygg C, Patel B, et al. 2006; Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem 99: 1285-1297.
23. 2 monoliths. J Appl Polym Sci 88: 3168-3175.
24. Karageorgiou V, Kaplan D. 2005; Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26: 5474-5491.
25. Kern S, Eichler H, Stoeve J, et al. 2006; Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301.
26. Keselowsky BG, Collard DM, García AJ. 2005; Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation. Proc Natl Acad Sci USA 102: 5953-5957.
27. Kirsebom H, Aguilar MR, Roman JS, et al. 2007; Macroporous scaffolds based on chitosan and bioactive molecules. J Bioact Compat Pol 22: 621-636.
28. Lacey DL, Timms E, Tan HL, et al. 1998; Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
29. Larraz E, Deb S, Elvira C, et al. 2006; A novel amphiphilic acrylic copolymer based on Triton X-100 for a poly(alkenoate) glass-ionomer cement. Dent Mater 22: 506-514.
30. Larraz E, Elvira C, San Roman J. 2005; Design and properties of novel self-curing acrylic formulations for application in intervertebral disks restoration. Biomacromolecules 6: 2058-2066.
31. Lee DH, Condrate RA, Reed JS. 1996; Infrared spectral investigation of polyacrylate adsorption on alumina. J Mater Sci 31(2): 471-478.
32. Lim JY, Taylor AF, Li Z, et al. 2005; Integrin expression and osteopontin regulation in human fetal osteoblastic cells mediated by substratum surface characteristics. Tissue Eng 11: 19-29.
33. Lozinsky VI. 2002; Cryogels on the basis of natural and synthetic polymers: preparation, properties and apllications. Russ Chem Rev 71: 489-511.
34. Maltese A, Borzacchiello A, Mayol L, et al. 2006; Novel polysaccharides-based viscoelastic formulations for ophthalmic surgery: rheological characterization. Biomaterials 27: 5134-5142.
35. Moursi AM, Damsky CH, Lull J, et al. 1996; Fibronectin regulates calvarial osteoblast differentiation. J Cell Sci 109: 1369-1380.
36. Mukherjee BB, Nemir M, Beninati S, et al. 1995; Interaction of osteopontin with fibronectin and other extracellular matrix molecules. Ann NY Acad Sci 760: 201-212.
37. Navarro M, Aparicio C, Charles-Harris M. 2006; Development of a biodegradable composite scaffold for bone tissue engineering: physicochemical, topographical, mechanical, degradation, and biological properties. Ordered Polym Nanostruct Surfaces 200: 209-231.
38. Park J. 2008; Bioceramics: Properties, Characterizations and Applications. Springer: Iowa City, IA, USA.
39. Perova TS, Vij JK, Xu H. 1997; Fourier transform infrared study of poly(2-hydroxyethyl methacrylate) (PHEMA). Colloid Polym Sci 275: 323-332.
40. Plieva FM, Karlsson M, Aguilar MR, et al. 2005; Pore structure in supermacroporous polyacrylamide based cryogels. Soft Matter 1: 303-309.
41. Ptacek P, Noskova M, Brandstetr J, et al. 2010; Dissolving behavior and calcium release from fibrous wollastonite in acetic acid solution. Thermochim Acta 498: 54-60.
42. Rezwan K, Chen QZ, Blaker JJ, et al. 2006; Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27: 3413-3431.
43. Rodríguez-Lorenzo LM. Vallet-Regí M, Ferreira JMF. 2002; Fabrication of porous hydroxyapatite bodies by a direct consolidation method, starch consolidation. J Biomed Mater Res 60: 232-240.
44. Rodríguez-Lorenzo LM, García-Carrodeguas R, Rodríguez MA, et al. 2008; Modulation of porosity in ceramic/bioresorbable polymer hybrid scaffolds for bone engineering. Transactions of the 8th World Biomaterials Conference; 2039.
45. Rodriguez-Lorenzo LM, Garcia-Carrodeguas R, Rodriguez MA, et al. 2009; Synthesis, characterization, bioactivity and biocompatibility of nanostructured materials based on the wollastonite-poly(ethylmethacrylate-co-vinylpyrrolidone) system. J Biomed Mater Res A 88: 53-64.
46. Sarmento C, Luklinska ZB, Brown L, et al. 2004; In vitro behaviour of osteoblastic cells cultured in the presence of pseudowollastonite ceramic. J Biomed Mater Res A 69: 351-358.
47. Schinköthe T, Bloch W, Schmidt A 2008; In vitro secreting profile of human mesenchymal stem cells. Stem Cells Dev 17: 199-206.
48. Semon JA, Nagy LH, Llamas CB, et al. 2010; Integrin expression and integrin-mediated adhesion in vitro of human multipotent stromal cells (MSCs) to endothelial cells from various blood vessels. Cell Tissue Res 341: 147-158.
49. Simonet WS, Lacey DL, Dunstan CR, et al. 1997; Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309-319.
50. Sottile J, Hocking DC. 2002; Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell 13: 3546-3559.
51. Uccelli A, Moretta L, Pistoia V. 2008; Mesenchymal stem cells in health and disease. Nat Rev Immunol 8: 726-736.
52. Volkmer E, Drosse I, Otto S, et al. 2008; Hypoxia in static and dynamic 3D culture systems for tissue engineering of bone. Tissue Eng A 14: 1331-1340.
53. Wagner W, Wein F, Seckinger A, et al. 2005; Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33: 1402-1416.
54. Yasuda H, Shima N, Nakagawa N, et al. 1998; Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139: 1329-1337.
55. Zhao W, Zhang Q, Peng C. 2006; FTIR spectra for molecular structure of wollastonite. J Chin Ceram Soc 34: 1137-1139.
56. Zhou Y, Chen F, Ho ST, et al. 2007; Combined marrow stromal cell-sheet techniques and high-strength biodegradable composite scaffolds for engineered functional bone grafts. Biomaterials 28: 814-824.